PDCD1 and neoplasm: The PLGA (PD-L1 siRNA+PD-1 siRNA)-NPs with vaccination group showed significant inhibition of tumor growth as compared with the positive control with vaccination (84% decrease, p<0.01) and anti-PD-L1+anti-PD-1 with vaccination groups (74% decrease, p<0.01, figure 5B).